Evidence map›Paper›PMID 40135871›Full record

ArticlemBio2025

Herpes simplex virus type 1 impairs mucosal-associated invariant T cells.

Lauren Stern, Zoe Emanuel, Renee Traves, Katherine Willis, Shivam K Purohit, Carolyn Samer, Jeffrey Y W Mak, David P Fairlie, David C Tscharke, Alexandra J Corbett and 2 more

Abstract read
In one paragraph

Article in mBio, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Lauren Stern *Infection, Immunity, and Inflammation, School of Medical Sciences, Faculty of Medicine and Health, Sydney, New South Wales, Australia.ORCID 0000-0002-9455-0008
Zoe Emanuel *Infection, Immunity, and Inflammation, School of Medical Sciences, Faculty of Medicine and Health, Sydney, New South Wales, Australia.
Renee Traves *Infection, Immunity, and Inflammation, School of Medical Sciences, Faculty of Medicine and Health, Sydney, New South Wales, Australia.
Katherine Willis *Infection, Immunity, and Inflammation, School of Medical Sciences, Faculty of Medicine and Health, Sydney, New South Wales, Australia.
Shivam K PurohitInfection, Immunity, and Inflammation, School of Medical Sciences, Faculty of Medicine and Health, Sydney, New South Wales, Australia.
Carolyn SamerInfection, Immunity, and Inflammation, School of Medical Sciences, Faculty of Medicine and Health, Sydney, New South Wales, Australia.ORCID 0000-0001-7838-9958
Jeffrey Y W MakARC Centre of Excellence for Innovations in Peptide and Protein Science, Institute for Molecular Bioscience, University of Queensland, Brisbane, Queensland, Australia.
David P FairlieARC Centre of Excellence for Innovations in Peptide and Protein Science, Institute for Molecular Bioscience, University of Queensland, Brisbane, Queensland, Australia.ORCID 0000-0002-7856-8566
David C TscharkeJohn Curtin School of Medical Research, Australian National University, Canberra, Australian Capital Territory, Australia.ORCID 0000-0001-6825-9172
Alexandra J CorbettDepartment of Microbiology and Immunology, University of Melbourne at the Peter Doherty Institute for Infection and Immunity, Melbourne, Victoria, Australia.ORCID 0000-0003-1618-4337
Allison Abendroth *Infection, Immunity, and Inflammation, School of Medical Sciences, Faculty of Medicine and Health, Sydney, New South Wales, Australia.ORCID 0000-0002-9794-4803
Barry Slobedman *Infection, Immunity, and Inflammation, School of Medical Sciences, Faculty of Medicine and Health, Sydney, New South Wales, Australia.ORCID 0000-0002-9431-6094

Funding

Investigating the basis of MAIT cell antigen potencyR01AI148407 · NIAID · UNIVERSITY OF MELBOURNE · PI MCCLUSKEY, JAMES · 2020 to 2024
$2.7M
Dame Kate Campbell FellowshipDepartment of Education and Training | Australian Research Council (ARC) CE200100012DHAC | National Health and Medical Research Council (NHMRC) GNT1193745DHAC | National Health and Medical Research Council (NHMRC) GNT2003395, GNT2008990DHAC | National Health and Medical Research Council (NHMRC) GNT2009551DHAC | National Health and Medical Research Council (NHMRC) GNT2019871HHS | National Institutes of Health (NIH) R01AI14807-01A1NIAID NIH HHS R01 AI148407
6 · The paper itself

Abstract

Herpes simplex virus type 1 (HSV-1) is a highly successful pathogen that infects mucosal sites and adopts an arsenal of strategies to manipulate host immunity. Mucosal-associated invariant T (MAIT) cells are abundant innate-like T lymphocytes that recognize bacterial and fungal-derived vitamin B-related metabolites presented by major histocompatibility complex class I-related protein 1 (MR1). MAIT cells can also be activated in an MR1-independent manner via cytokine stimulation, predominantly by IL-12 and IL-18. MAIT cell alterations have been identified as being associated with a number of viral infections, but direct interactions between viruses and MAIT cells are poorly understood. It is unknown whether HSV-1 can infect MAIT cells and modulate their functions. Here, we show that HSV-1 can infect primary human MAIT cells, including CD4 IMPORTANCE: Mucosal-associated invariant T cells (MAIT cells) are "unconventional" immune cells that are becoming increasingly appreciated to play important roles in a variety of viral infections. Herpes simplex virus (HSV) causes significant human disease and is a master manipulator of multiple immune functions, but how this virus may control MAIT cells is poorly understood. We discovered that HSV can infect human MAIT cells and impair their functional capacity and also show that MAIT cells exposed to HSV, but which do not show evidence of infection, are similarly impaired. This study therefore identifies an additional immunomodulatory function of HSV.

Indexed as

Herpes SimplexHerpesvirus 1, HumanMucosal-Associated Invariant T CellsCells, CulturedCytokinesHistocompatibility Antigens Class IHumansInterleukin-18CytokinesHistocompatibility Antigens Class IInterleukin-18herpes simplex virusherpesvirusHSVHSV-1immune modulationMAIT cellmucosal-associated invariant T cell

Identifiers

PMID40135871
PMCPMC12077205

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.